Serdar Arısan

455 total citations
29 papers, 352 citations indexed

About

Serdar Arısan is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Serdar Arısan has authored 29 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Serdar Arısan's work include Bladder and Urothelial Cancer Treatments (6 papers), Renal cell carcinoma treatment (3 papers) and Urinary Bladder and Prostate Research (3 papers). Serdar Arısan is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Renal cell carcinoma treatment (3 papers) and Urinary Bladder and Prostate Research (3 papers). Serdar Arısan collaborates with scholars based in Türkiye, Czechia and Antigua and Barbuda. Serdar Arısan's co-authors include Erbil Ergenekon, Narçın Palavan-Ünsal, Elif Damla Arısan, Turhan Çaşkurlu, Ömer Onur Çakır, Guy H. Grant, Pinar Uysal‐Onganer, D. Alwyn Dart, Sigrun Lange and Murat Can Kiremit and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Alloys and Compounds and Viruses.

In The Last Decade

Serdar Arısan

28 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serdar Arısan Türkiye 9 144 85 70 63 61 29 352
Shashank Pandya India 9 55 0.4× 28 0.3× 95 1.4× 28 0.4× 16 0.3× 53 286
Alejandro Livoff Israel 10 63 0.4× 25 0.3× 52 0.7× 10 0.2× 16 0.3× 29 266
Shan Zhong China 11 119 0.8× 52 0.6× 158 2.3× 6 0.1× 61 1.0× 18 461
Mostafa Mehrabi Bahar Iran 13 71 0.5× 22 0.3× 154 2.2× 17 0.3× 20 0.3× 28 326
Amir Hamza Germany 12 76 0.5× 26 0.3× 121 1.7× 4 0.1× 56 0.9× 35 401
David Rodriguez‐Buritica United States 12 161 1.1× 9 0.1× 74 1.1× 18 0.3× 23 0.4× 37 429
Kiminobu Sugito Japan 12 115 0.8× 33 0.4× 217 3.1× 18 0.3× 7 0.1× 47 404
Petr Jabandžiev Czechia 11 47 0.3× 36 0.4× 135 1.9× 9 0.1× 7 0.1× 60 319
Kensuke Ohashi Japan 12 94 0.7× 21 0.2× 172 2.5× 17 0.3× 10 0.2× 33 338

Countries citing papers authored by Serdar Arısan

Since Specialization
Citations

This map shows the geographic impact of Serdar Arısan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serdar Arısan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serdar Arısan more than expected).

Fields of papers citing papers by Serdar Arısan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serdar Arısan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serdar Arısan. The network helps show where Serdar Arısan may publish in the future.

Co-authorship network of co-authors of Serdar Arısan

This figure shows the co-authorship network connecting the top 25 collaborators of Serdar Arısan. A scholar is included among the top collaborators of Serdar Arısan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serdar Arısan. Serdar Arısan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arısan, Serdar, et al.. (2025). Targeting Methionine Metabolism Reveals AMPK-SAMTOR Signaling as a Therapeutic Vulnerability in Prostate Cancer. Biology. 14(5). 507–507. 1 indexed citations
3.
Horasanlı, Kaya, et al.. (2016). The importance of active surveillance, and immediate re-biopsy in low-risk prostate cancer: The largest series from Turkey. SHILAP Revista de lepidopterología. 42(3). 140–144. 2 indexed citations
5.
Çoşkun, Burhan, et al.. (2013). A case of seminal vesicle cyst associated with ipsilateral renal agenesis diagnosed during an investigation of urinary incontinence. SHILAP Revista de lepidopterología. 39(1). 53–55. 5 indexed citations
6.
Gürkan, Ajda Çoker, Serdar Arısan, Elif Damla Arısan, & Narçın Palavan-Ünsal. (2013). Lack of evidence for the association of ornithine decarboxylase (+316 G>A), spermidine/spermine acetyl transferase (−1415 T>C) gene polymorphisms with calcium oxalate stone disease. Biomedical Reports. 2(1). 69–74. 3 indexed citations
7.
Gürkan, Ajda Çoker, et al.. (2013). Association between IL-1RN VNTR, IL-1β -511 and IL-6 (-174, -572, -597) Gene Polymorphisms and Urolithiasis. Urologia Internationalis. 91(2). 220–226. 7 indexed citations
8.
Arısan, Serdar, et al.. (2012). Bilateral Leydig cell tumor of the testis: a. Współczesna Onkologia. 4(4). 356–359. 5 indexed citations
9.
Tanrıverdi, Orhan, et al.. (2012). How and When to Perform Transcatheter Embolization in Iatrogenic Renal Hemorrhage? A New Algorithm. 28(2). 84–93. 1 indexed citations
10.
Kiremit, Murat Can, et al.. (2010). Sexual dysfunction in type III chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS) observed in Turkish patients. International Urology and Nephrology. 43(2). 309–314. 30 indexed citations
11.
Çoşkun, Burhan, et al.. (2009). Early penile metastasis from primary bladder cancer as the first systemic manifestation: a case report. Cases Journal. 2(1). 7281–7281. 12 indexed citations
12.
Atış, Gökhan, et al.. (2009). Tissue Reaction of the Rat Urinary Bladder to Synthetic Mesh Materials. The Scientific World JOURNAL. 9. 1046–1051. 7 indexed citations
13.
Arısan, Elif Damla, Serdar Arısan, Gökhan Atış, Narçın Palavan-Ünsal, & Erbil Ergenekon. (2009). Serum Adipocytokine Levels in Prostate Cancer Patients. Urologia Internationalis. 82(2). 203–208. 33 indexed citations
14.
Arısan, Serdar, Murat Can Kiremit, & Erbil Ergenekon. (2008). Determination of IL-10 levels in syndrome patients. 1 indexed citations
15.
Tuğcu, Volkan, Emin Özbek, Bekir Aras, et al.. (2007). Manganese superoxide dismutase (Mn-SOD) gene polymorphisms in urolithiasis. Urological Research. 35(5). 219–224. 19 indexed citations
16.
Arısan, Elif Damla, Serdar Arısan, Murat Can Kiremit, et al.. (2006). Manganase superoxide dismutase polymorphism in chronic pelvic pain syndrome patients. Prostate Cancer and Prostatic Diseases. 9(4). 426–431. 20 indexed citations
17.
Arısan, Serdar, et al.. (2005). The Prognostic Importance of E-cadherin and p53 Gene Expression in Transitional Bladder Carcinoma Patients. International Urology and Nephrology. 37(3). 485–492. 8 indexed citations
18.
Arısan, Serdar, et al.. (2005). Increased Expression of EZH2, a Polycomb Group Protein, in Bladder Carcinoma. Urologia Internationalis. 75(3). 252–257. 76 indexed citations
19.
Arısan, Serdar, et al.. (2004). Bladder tumor antigen sensitivity in bladder cancer patients. 2 indexed citations
20.
Arısan, Serdar, et al.. (2003). Primary adenocarcinoma of the epididymis: Case report. International Urology and Nephrology. 36(1). 77–80. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026